HBsAg Isoforms as Innovative Biomarkers in Predicting Virological Response to Bulevirtide in Patients With Chronic Hepatitis D
Latest Information Update: 20 May 2025
At a glance
- Drugs Bulevirtide (Primary)
- Indications Hepatitis D
- Focus Biomarker; Pharmacodynamics
Most Recent Events
- 20 May 2025 New trial record
- 01 May 2025 Results published in the Liver International